Francesca Guideri Selected Research

Mechanical Thrombolysis

1/2022	Safety of Intravenous Thrombolysis and Mechanical Thrombectomy in Bilateral Posterior Cerebral Artery Territory Infarction.
1/2021	Outcome After Acute Ischemic Stroke Treatment During Covid-19 Outbreak in South-East Tuscany.
1/2014	Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Guideri Research Topics

Disease

13	Ischemic Stroke 12/2023 - 11/2011
13	Stroke (Strokes) 01/2022 - 01/2013
10	Atrial Fibrillation 01/2022 - 08/2015
7	Hemorrhage 12/2020 - 01/2014
4	Cerebral Hemorrhage 01/2021 - 01/2014
3	Inflammation (Inflammations) 06/2019 - 05/2016
2	Infarction (Infarctions) 01/2022 - 11/2011
2	Embolic Stroke 01/2019 - 08/2015
2	Hyperhomocysteinemia 05/2016 - 01/2011
2	Myxoma (Myxomas) 01/2014 - 11/2011
2	Congenital heart block 09/2009 - 01/2008
1	Agnosia (Visual Agnosia) 01/2022
1	Cortical Blindness (Anton Syndrome) 01/2022
1	Leukoaraiosis 01/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2017
1	Atrial Remodeling 01/2017
1	Embolism (Embolus) 11/2011
1	Sudden Death 09/2009
1	Tachycardia (Tachyarrhythmias) 10/2008
1	Arthritis (Polyarthritis) 10/2008
1	Bradycardia 10/2008
1	Rett Syndrome (Rett's Disorder) 02/2008
1	Autonomic Nervous System Diseases (Dysautonomia) 02/2008
1	Cardiac Arrhythmias (Arrythmia) 01/2008
1	Autoimmune Diseases (Autoimmune Disease) 01/2008
1	Neonatal Systemic lupus erythematosus 05/2006
1	Heart Block 05/2006
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 05/2006
1	Connective Tissue Diseases (Connective Tissue Disease) 04/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2002
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2002
1	Ischemia 06/2002

Drug/Important Bio-Agent (IBA)

10	AnticoagulantsIBA 01/2021 - 08/2015
6	Vitamin K FDA Link 12/2023 - 11/2017
4	AntibodiesIBA 09/2009 - 04/2004
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2014 - 11/2011
2	C-Reactive ProteinIBA 06/2019 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 01/2015
2	AutoantibodiesIBA 01/2008 - 05/2006
1	Heparin (Liquaemin)FDA LinkGeneric 12/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	Dabigatran FDA Link 11/2017
1	RivaroxabanIBA 11/2017
1	apixabanIBA 11/2017
1	HomocysteineIBA 05/2016
1	Antihypertensive Agents (Antihypertensives)IBA 01/2015
1	Dihydrotachysterol (AT 10)IBA 01/2013
1	Infliximab (Remicade)FDA Link 10/2008
1	LeptinIBA 02/2008
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2008
1	DEET (DET)IBA 06/2002
1	Dipyridamole (Persantine)FDA LinkGeneric 06/2002
1	Adenosine (Adenocard)FDA LinkGeneric 06/2002

Therapy/Procedure

11	Therapeutics 12/2023 - 11/2011
3	Mechanical Thrombolysis 01/2022 - 01/2014
3	Thrombectomy 01/2022 - 09/2017
3	Thrombolytic Therapy 01/2020 - 01/2014
3	Secondary Prevention 01/2020 - 02/2016
2	Heart Transplantation (Grafting, Heart) 05/2016 - 01/2011
1	Operative Surgical Procedures 05/2016
1	Activities of Daily Living (ADL) 01/2013
1	Aftercare (After-Treatment) 11/2011